An Intuitionistic Fuzzy Set Analysis of Drug-Target Interactions

被引:0
|
作者
Maggiora, Gerry [1 ]
Szmidt, Eulalia [2 ,3 ]
机构
[1] Univ Arizona, BIO5 Inst, Tucson, AZ 85718 USA
[2] Polish Acad Sci, Syst Res Inst, Newelska 6, PL-01447 Warsaw, Poland
[3] Warsaw Sch Informat Technol, Ul Newelska 6, PL-01447 Warsaw, Poland
关键词
SCORING FUNCTIONS; SIMILARITY; DISCOVERY; PREDICTION; POLYPHARMACOLOGY; DATABASES; LIGANDS; DOCKING; SYSTEMS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The use of drugs in modern medicine is widespread and no doubt has played a significant role in improving outcomes in the treatment of many medical conditions. Hence, the discovery of drugs for new therapeutic indications as well drugs of enhanced efficacy for existing indications are of paramount importance. Information on drug-target interactions plays an important role in this task its importance is reflected by the fact that searching the Internet based on 'drug-target interaction' yields 280,000,000 hits. The interaction of a given drug with respect to multiple drug targets also known as polypharmacology is becoming increasingly important in modern drug research as it bears on the role of the biological pathways underlying a drug's mechanism(s) of action, the existence of side-effects, and the repurposing of existing drugs for new therapeutic indications. The ability of multiple, structurally dissimilar drugs to interact with a given target, also known as polyspecificity, is the complement of polypharmacology, and while not as well-known has nevertheless played a role in drug discovery research under the rubric of multiple lead series. Both of these concepts are considered in this work. Although sets of n drugs and m targets give rise to n X m virtual drug-target pairs, experimental and computational interaction data typically exist for only a small subset of these pairs. Thus, polypharmacology and polyspecificity values will, in all likelihood, be underestimated. As is shown in this work, taking account of drug-target pairs of unknown interaction (i.e. 'null' pairs) yields an upper bound to these values. However, in order to include such information in their analysis it is desirable that a methodology be able to handle null pairs in a reasonably straightforward manner. This is not the case with classical sets where the interaction of drug-target pairs is typically represented by set-theoretic relations, where a '1' indicates the presence of an interactive drug-target pair- with respect to a given interaction threshold and a '0' indicates the presence of a non-interactive pair. A new set-theoretic formalism based on extreme-value intuitionistic fuzzy sets (IFS) is utilized in this work since it explicitly accounts for the uncertainty inherent in null drug-target pairs. As will be demonstrated in future work, it can be generalized to include drug-target pairs with real-valued interactions. A simple example dataset is provided illustrating the application of IFSs to the analysis of drug-target datasets.
引用
收藏
页码:465 / 498
页数:34
相关论文
共 50 条
  • [1] Identification of drug-target interactions via fuzzy bipartite local model
    Ding, Yijie
    Tang, Jijun
    Guo, Fei
    [J]. NEURAL COMPUTING & APPLICATIONS, 2020, 32 (14): : 10303 - 10319
  • [2] A landscape for drug-target interactions based on network analysis
    Galan-Vasquez, Edgardo
    Perez-Rueda, Ernesto
    [J]. PLOS ONE, 2021, 16 (03):
  • [3] Predicting Drug-Target Interactions Using Drug-Drug Interactions
    Kim, Shinhyuk
    Jin, Daeyong
    Lee, Hyunju
    [J]. PLOS ONE, 2013, 8 (11):
  • [4] DRUG-TARGET INTERACTIONS Stay tuned
    Copeland, Robert A.
    [J]. NATURE CHEMICAL BIOLOGY, 2015, 11 (07) : 451 - 452
  • [5] In silico analysis of alternative splicing on drug-target gene interactions
    Ji, Yanrong
    Mishra, Rama K.
    Davuluri, Ramana, V
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] In silico analysis of alternative splicing on drug-target gene interactions
    Yanrong Ji
    Rama K. Mishra
    Ramana V. Davuluri
    [J]. Scientific Reports, 10
  • [7] The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
    Copeland, Robert A.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (04) : 305 - 310
  • [8] Drug-Target Interactions: Prediction Methods and Applications
    Anusuya, Shanmugam
    Kesherwani, Manish
    Priya, K. Vishnu
    Vimala, Antonydhason
    Shanmugam, Gnanendra
    Velmurugan, Devadasan
    Gromiha, M. Michael
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2018, 19 (06) : 537 - 561
  • [9] Identifying Drug-Target Interactions with Decision Templates
    Yan, Xiao-Ying
    Zhang, Shao-Wu
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2018, 19 (05) : 498 - 506
  • [10] Kinetic analysis of drug-target interactions with PET for characterization of pharmacological hysteresis
    Salinas, Cristian
    Weinzimmer, David
    Searle, Graham
    Labaree, David
    Ropchan, Jim
    Huang, Yiyun
    Rabiner, Eugenii A.
    Carson, Richard E.
    Gunn, Roger N.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (05): : 700 - 707